glucagon receptor retatrutide Retatrutide. The next evolution. A next-generation triple agonist designed to advance metabolic research through GLP-1, GIP, and pathways. Supporting innovation through trusted peptide sourcing. For healthcare professionals. Research retatrutide glp-1 gip glucagon receptor

A mere decade ago, obesity drugs powerful enough for people to routinely drop double-digit percentages of their body weight were unheard-of

The emphasis will shift from merely treating symptoms to understanding and supporting the skin's inherent functions

If eligible, the provider will submit a prior authorization to your insurance, and once approved, the prescription is sent to your pharmacy or delivered to your home

Research-grade peptides are manufactured for laboratory settings, are labeled "not for human use," and are not subject to the same regulatory oversight

Cecilia Low Wang, a UCHealth expert on endocrinology, diabetes and metabolism